
    
      Participants will be enrolled in three age cohorts: Children: 2 - 11 years of age;
      Adolescents: 12 - 17 years of age, and Adults: 18 - 55 years of age to receive a single dose
      of MenactraÂ®. They will be followed for a duration of 30 days after vaccination.
    
  